Comparative efficacy of long-acting β2-agonists as monotherapy for chronic obstructive pulmonary disease: a network meta-analysis

Overview of attention for article published in International Journal of Chronic Obstructive Pulmonary Disease, January 2017

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (68th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 5 X users

Citations

dimensions_citation: 27 Dimensions

Readers on

mendeley: 55 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 27 publications that cite this research output.

27

The most recent citing publications are shown below. View all 27 publications that cite this research output on Dimensions.

The optimal dose of indacaterol for treatment of chronic obstructive pulmonary disease: a systematic review and Bayesian network meta-analysis

Article in Journal of Thoracic Disease (January 2024)

New Perspectives in Pharmacological Therapy for COPD: Phenotype Classification and Corticosteroids with Bronchodilators

Book chapter (February 2023)

Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate: A Combination Therapy for Asthma

Article in Current Respiratory Medicine Reviews (January 2022)